Premium
[P‐011]: Plasma AB levels as a premorbid biomarker for cognitive decline, mild cognitive impairment (MCI) and Alzheimer disease (AD)
Author(s) -
Graff-Radford Neill R.,
Lucas John A.,
Crook Julia E.,
Boeve Bradley F.,
Knopman David S.,
Ivnik Robert J.,
Younkin Linda H.,
Petersen Ronald C.,
Younkin Steven G.
Publication year - 2005
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2005.06.073
Subject(s) - cognitive decline , medicine , dementia , biomarker , cognitive impairment , proportional hazards model , cognition , psychology , oncology , disease , gastroenterology , endocrinology , psychiatry , chemistry , biochemistry